Abstract
Study Objective: To determine how much money patients are willing to pay to avoid postoperative muscle pains associated with succinylcholine. Design: Observational study with survey instrument. Setting: University-affiliated metropolitan hospital. Patients: Eighty-eight adult patients, 43 men and 45 women, who were scheduled to undergo surgery with general anesthesia and who completed a preoperative questionnaire (median age range, 41-50 y; median income, US$45,000-60,000). Interventions and Measurements: Patients completed a computerized, interactive questionnaire preoperatively. They were asked about demographics and previous experiences with muscle pain and postoperative myalgia. With the use of the willingness-to-pay model, the value that they would be willing to pay for a hypothetical muscle relaxant that avoided postoperative myalgia was determined. Main Results: Eighty-nine percent of patients considered avoiding postoperative myalgia as important. Patients were willing to pay a median (interquartile range) of $33 ($19-$50) out of pocket for a muscle relaxant that was not associated with postoperative myalgia, a figure that increased to $40 if the insurance company paid for the drug (P < 0.0001). Willingness to pay was influenced by patients' income but not by prior experience with postoperative myalgia. Conclusion: Patients consider avoidance of postoperative myalgia important and are willing to pay $33 out of pocket for a muscle relaxant that is not associated with this side effect.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 601-608 |
| Number of pages | 8 |
| Journal | Journal of Clinical Anesthesia |
| Volume | 19 |
| Issue number | 8 |
| DOIs | |
| State | Published - Dec 1 2007 |
| Externally published | Yes |
Fingerprint
Keywords
- Cost-benefit analysis
- Postoperative myalgia
- Succinylcholine
- Willingness to pay
ASJC Scopus subject areas
- Anesthesiology and Pain Medicine
Cite this
How much are patients willing to pay to avoid postoperative muscle pain associated with succinylcholine? / Allen, Terrence K.; Habib, Ashraf S.; Dear, Guy L.; White, William; Lubarsky, David; Gan, Tong J.
In: Journal of Clinical Anesthesia, Vol. 19, No. 8, 01.12.2007, p. 601-608.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - How much are patients willing to pay to avoid postoperative muscle pain associated with succinylcholine?
AU - Allen, Terrence K.
AU - Habib, Ashraf S.
AU - Dear, Guy L.
AU - White, William
AU - Lubarsky, David
AU - Gan, Tong J.
PY - 2007/12/1
Y1 - 2007/12/1
N2 - Study Objective: To determine how much money patients are willing to pay to avoid postoperative muscle pains associated with succinylcholine. Design: Observational study with survey instrument. Setting: University-affiliated metropolitan hospital. Patients: Eighty-eight adult patients, 43 men and 45 women, who were scheduled to undergo surgery with general anesthesia and who completed a preoperative questionnaire (median age range, 41-50 y; median income, US$45,000-60,000). Interventions and Measurements: Patients completed a computerized, interactive questionnaire preoperatively. They were asked about demographics and previous experiences with muscle pain and postoperative myalgia. With the use of the willingness-to-pay model, the value that they would be willing to pay for a hypothetical muscle relaxant that avoided postoperative myalgia was determined. Main Results: Eighty-nine percent of patients considered avoiding postoperative myalgia as important. Patients were willing to pay a median (interquartile range) of $33 ($19-$50) out of pocket for a muscle relaxant that was not associated with postoperative myalgia, a figure that increased to $40 if the insurance company paid for the drug (P < 0.0001). Willingness to pay was influenced by patients' income but not by prior experience with postoperative myalgia. Conclusion: Patients consider avoidance of postoperative myalgia important and are willing to pay $33 out of pocket for a muscle relaxant that is not associated with this side effect.
AB - Study Objective: To determine how much money patients are willing to pay to avoid postoperative muscle pains associated with succinylcholine. Design: Observational study with survey instrument. Setting: University-affiliated metropolitan hospital. Patients: Eighty-eight adult patients, 43 men and 45 women, who were scheduled to undergo surgery with general anesthesia and who completed a preoperative questionnaire (median age range, 41-50 y; median income, US$45,000-60,000). Interventions and Measurements: Patients completed a computerized, interactive questionnaire preoperatively. They were asked about demographics and previous experiences with muscle pain and postoperative myalgia. With the use of the willingness-to-pay model, the value that they would be willing to pay for a hypothetical muscle relaxant that avoided postoperative myalgia was determined. Main Results: Eighty-nine percent of patients considered avoiding postoperative myalgia as important. Patients were willing to pay a median (interquartile range) of $33 ($19-$50) out of pocket for a muscle relaxant that was not associated with postoperative myalgia, a figure that increased to $40 if the insurance company paid for the drug (P < 0.0001). Willingness to pay was influenced by patients' income but not by prior experience with postoperative myalgia. Conclusion: Patients consider avoidance of postoperative myalgia important and are willing to pay $33 out of pocket for a muscle relaxant that is not associated with this side effect.
KW - Cost-benefit analysis
KW - Postoperative myalgia
KW - Succinylcholine
KW - Willingness to pay
UR - http://www.scopus.com/inward/record.url?scp=36849013692&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=36849013692&partnerID=8YFLogxK
U2 - 10.1016/j.jclinane.2007.07.005
DO - 10.1016/j.jclinane.2007.07.005
M3 - Article
C2 - 18083474
AN - SCOPUS:36849013692
VL - 19
SP - 601
EP - 608
JO - Journal of Clinical Anesthesia
JF - Journal of Clinical Anesthesia
SN - 0952-8180
IS - 8
ER -